This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n7http://linked.opendata.cz/resource/drugbank/drug/DB04669/identifier/chemspider/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB04669/identifier/bindingdb/
n10http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB04669/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04669/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04669/identifier/pubchem-substance/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n15http://linked.opendata.cz/resource/drugbank/drug/DB04669/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04669
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB04669 n11:DB04669
dcterms:title
TRIAZOLOPYRIMIDINE
adms:identifier
n4:CT8 n5:11457 n7:4484381 n13:5327131 n14:46505862 n15:DB04669
n6:synthesisReference
Nicole Bru-Magniez, Eric Nicolai, Jean-Marie Teulon, "Triazolopyrimidine derivatives which are angiotensin II receptor antagonists processes for preparing them and pharmaceutical compositions containing them." U.S. Patent US5217973, issued March, 1964.
n6:IUPAC-Name
n8:271B485B-363D-11E5-9242-09173F13E4C5
n6:InChI
n8:271B4861-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n8:271B4860-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n8:271B485D-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n8:271B485E-363D-11E5-9242-09173F13E4C5
n6:SMILES
n8:271B485F-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n8:271B4859-363D-11E5-9242-09173F13E4C5
n6:logP
n8:271B4857-363D-11E5-9242-09173F13E4C5 n8:271B485A-363D-11E5-9242-09173F13E4C5
n6:logS
n8:271B4858-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n8:271B4867-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n8:271B4868-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n8:271B4862-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n8:271B4863-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n8:271B4865-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n8:271B4864-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n8:271B4866-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n8:271B486D-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n8:271B486F-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n8:271B4870-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n8:271B486C-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n8:271B486B-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n8:271B486E-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n8:271B485C-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n8:271B4869-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n8:271B486A-363D-11E5-9242-09173F13E4C5